Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.475
-0.065 (-4.22%)
At close: Apr 28, 2026, 4:00 PM EDT
1.560
+0.085 (5.76%)
After-hours: Apr 28, 2026, 7:28 PM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $10.62 million as of April 28, 2026. Its market cap has decreased by -40.08% in one year.
Market Cap
10.62M
Enterprise Value
146.57K
1-Year Change
-40.08%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $10.62M, a decrease of -98.32%. That is a compound annual growth rate of -55.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 11.09M | 9.18% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CDT Equity | 12.10M |
| BioVie | 11.99M |
| CytoMed Therapeutics | 11.60M |
| Traws Pharma | 11.58M |
| Reviva Pharmaceuticals Holdings | 11.32M |
| Lunai Bioworks | 11.19M |
| Cellectar Biosciences | 11.07M |
| Imunon | 10.98M |